Neogenomics IncHere is the public summary page for Neogenomics Inc. Please login to see the complete information for Neogenomics Inc including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Neogenomics Inc stacks up relative to its peers. |
Darwin Score | +12 |
Ticker | NEO |
Latest Price | 7.45 USD as of close on 08-Jul-2025 |
3 Month price range | 6.40 to 10.27 USD |
Market Capitalisation | 958.78Mn USD |
Country | United States of America |
Region | North America |
Economic Sector | Health Care |
Business Sector | Health Care Equipment & Services |
Industry | Health Care Providers & Services |
Sub-Industry | Health Care Services |
Description | NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida. See More ... |
Company URL | https://www.neogenomics.com |
See Darwins Full Analysis for Neogenomics Inc |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Neogenomics Inc. Further information and full detail is available when you login.
TMA Part | Focus of Analysis | TMA Score |
---|---|---|
Price | Analysis of performance, trend, RSI, OBV and moving averages | +10 |
Sentiment | News and Candle Patterns. | 0 |
Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | -10 |
Flow | Institutional, Fund and Insider buying and selling. | +7 |
Models | Forecast models. | +5 |
Alerts
There are 3 live alerts for Neogenomics Inc. All the alerts are positive.
- Oversold - The 5 month RSI is +13.4. (Positive)
- Oversold - The 15 month RSI is +29.8. (Positive)
- Price crossing up through 5 day SMA. This alert has occurred 30 times over the last last year. The average forward returns are -2.0% over 5 days, -2.5% over 10 days, -3.9% over 15 days and -3.5% over 20 days. (Positive)
Peer Comparison
There is 1 peer of Neogenomics Inc.
Asset Name | Industry Group | Asset Score |
---|---|---|
Astrana Health Inc (ASTH) | Health Care Services | -4 |